Abstract
The recent use of chemical genomics to identify bioactive small molecules that interact with specific proteins has had a tremendous impact on both the functional analysis of genes and drug development. Accordingly, the current review focuses on the utilization of this new research engine in the target identification and validation of antiangiogenic agents capable of regulating the growth and spread of cancer cells. In addition, the use of chemical genomics to discover novel anti-angiogenic agent targets and to validate their biological relevancy is providing new insights into the biological role of targets in angiogenesis as well as advancing the development of new antiangiogenic agents.
Keywords: chemical genomics, angiogenesis, anti-angiogenic agents, target identification and validation, methionine aminopeptidase II, hsp90, histone deacetylase
Current Medicinal Chemistry
Title: Chemical Genomics-Based Target Identification and Validation of Anti- Angiogenic Agents
Volume: 10 Issue: 9
Author(s): Ho Jeong Kwon
Affiliation:
Keywords: chemical genomics, angiogenesis, anti-angiogenic agents, target identification and validation, methionine aminopeptidase II, hsp90, histone deacetylase
Abstract: The recent use of chemical genomics to identify bioactive small molecules that interact with specific proteins has had a tremendous impact on both the functional analysis of genes and drug development. Accordingly, the current review focuses on the utilization of this new research engine in the target identification and validation of antiangiogenic agents capable of regulating the growth and spread of cancer cells. In addition, the use of chemical genomics to discover novel anti-angiogenic agent targets and to validate their biological relevancy is providing new insights into the biological role of targets in angiogenesis as well as advancing the development of new antiangiogenic agents.
Export Options
About this article
Cite this article as:
Kwon Jeong Ho, Chemical Genomics-Based Target Identification and Validation of Anti- Angiogenic Agents, Current Medicinal Chemistry 2003; 10(9) . https://dx.doi.org/10.2174/0929867033457755
DOI https://dx.doi.org/10.2174/0929867033457755 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Drug Development Strategy for Type 2 Diabetes: Targeting Positive Energy Balances
Current Drug Targets Myostatin Inhibition and Cardiometabolic Disorders
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization) Role of Insulin and Growth Hormone/Insulin-Like Growth Factor-I Signaling in Lifespan Extension: Rodent Longevity Models for Studying Aging and Calorie Restriction
Current Genomics Relationship between Diabetes Mellitus and Coronary Heart Disease
Current Diabetes Reviews Epigenetic control of cardiovascular health by nutritional polyphenols involves multiple chromatin-modifying writer-reader-eraser proteins
Current Topics in Medicinal Chemistry Tumor Necrosis Factor Alpha in Ulcerative Colitis and Diverticular Disease Associated Colitis
Endocrine, Metabolic & Immune Disorders - Drug Targets Inhibition of Dipeptidyl Peptidase-4 (DPP-4) - A Novel Approach to Treat Type 2 Diabetes
Current Enzyme Inhibition Postprandial Hypotension - Novel Insights into Pathophysiology and Therapeutic Implications
Current Vascular Pharmacology Periodontal Regenerative Materials and Their Applications: Goodness of Fit?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Tetrac-Conjugated Quantum Dots for Diagnosis and Treatment of Pancreatic Cancer: An In Vitro Evaluation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization) Insulin Resistance and Diabetes in HIV Infection
Recent Patents on Anti-Infective Drug Discovery The Heart in Sepsis: From Basic Mechanisms to Clinical Management
Current Vascular Pharmacology Targeting the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cells
Current Medicinal Chemistry Pathophysiology of Type 2 Diabetes in Children and Adolescents
Current Diabetes Reviews Model-Based Insulin and Nutrition Administration for Tight Glycaemic Control in Critical Care
Current Drug Delivery Micelle-based Systems for Pulmonary Drug Delivery and Targeting
Drug Delivery Letters Editorial (Thematic Issue: Controlled Release and Drug Delivery in Diseases)
Protein & Peptide Letters The Promise of Dolutegravir: A Novel Second Generation Integrase Strand Transfer Inhibitor
Current Clinical Pharmacology Airway Remodeling: Effect of Current and Future Asthma Therapies
Current Respiratory Medicine Reviews Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews